Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Prevalence and serological profile of occult hepatitis B virus infection in newly diagnosed cancer patients
Indian Journal of Medical Microbiology
1 September 2026
Sahu S.
Open Access
Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases
Animals
August 2025
Kondracki M.
Open Access
Research Progress in Adverse Reactions Caused by Obinutuzumab in the Treatment of Follicular Lymphoma
Chinese Journal of Pharmacovigilance
15 July 2025
Zhong X.
Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation
Journal of Clinical Medicine
March 2025
Paschereit A.
Open Access
Risk of HBV reactivation in psoriasis vulgaris patients receiving biological agent therapy
Cutaneous and Ocular Toxicology
2025
Kankılıç A.T.
Chinese expert consensus recommendations for prevention and management of hepatitis B and C virus reactivation in breast cancer patients during chemotherapy (2024 edition)
Chinese Journal of Endocrine Surgery
25 December 2024
Immune response to occult hepatitis B virus infection among hemodialysis patients: A review
Microbe Netherlands
December 2024
Mussa A.
Open Access
Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens
World Journal of Gastroenterology
28 November 2024
Lu R.
Open Access
SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection
Journal of Clinical Virology Plus
November 2023
Shoraka S.
Open Access
Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT
Iscience
17 March 2023
Ren J.
Open Access
Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study
Infection and Drug Resistance
1 December 2022
He P.
Open Access
Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
Pathogens
May 2022
Sagnelli C.
Open Access
Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort study
Journal of Infection and Chemotherapy
October 2021
Yonezawa H.
Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment
Asian Pacific Journal of Cancer Prevention
September 2021
Mahmoudvand S.
Open Access
A practical algorithm for non-hepatologists to prevent hepatitis B reactivation related to immunosuppressive treatment and chemotherapy
Acta Medica Mediterranea
2021
Ulasoglu C.
Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival
Cancer Science
1 November 2020
Qin S.K.
Open Access
Iranian guideline for rituximab therapy in pemphigus patients
Dermatologic Therapy
1 September 2019
Daneshpazhooh M.
Hepatitis B Reactivation Rate Is Higher Undergoing Some Cytotoxic Chemotherapy in Patients with Solid Tumors: A Large Retrospective Study
Chemotherapy
1 February 2019
Karaca M.
Tenofovir alafenamide: A new drug with various ambiguous aspects in treatment of chronic hepatitis b infection
Archives of Clinical Infectious Diseases
February 2019
Tavakolpour S.
Open Access
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Blood
10 January 2019
Kusumoto S.
Open Access
Hepatitis B virus reactivation in patients with hematological malignancies under lamivudine prophylaxis
Acta Medica Mediterranea
2019
Iskender G.
Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections
Blood Reviews
September 2018
Hilal T.